Center Laboratories, Inc.(TW:4123)
NT$28.40+0.15 (+0.53%)
TW:4123
Center Laboratories, Inc. financials statements
NT$28.40
At close:+0.15 (+0.53%)
Center Laboratories, Inc. (4123) Income Statement
Center Laboratories, Inc. Income Statement
Last quarter (Q2 2026), Center Laboratories, Inc.'s total revenue was NT$432.06M, an increase of 14.09% from the same quarter last year. In Q2, Center Laboratories, Inc.'s net income was NT$-10.45B. See Center Laboratories, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Mar 23 | Dec 21 |
|---|---|---|---|---|---|
| NT$ 1.52B | NT$ 1.62B | NT$ 1.39B | NT$ 767.72M | NT$ 500.11M | |
| NT$ 621.26M | NT$ 748.95M | NT$ 618.09M | NT$ 406.27M | NT$ 259.66M | |
| NT$ 982.88M | NT$ 514.63M | NT$ 539.54M | NT$ 121.83M | NT$ 513.81M | |
| Depreciation and Amortization | NT$ 173.30M | NT$ 161.07M | NT$ 147.94M | NT$ 33.02M | NT$ 34.57M |
| NT$ 11.95B | NT$ -232.41M | NT$ -765.79M | NT$ 232.50M | NT$ 2.73B | |
| NT$ -361.62M | NT$ 234.32M | NT$ 78.54M | NT$ 131.94M | NT$ 1.04B | |
| NT$ 11.93B | NT$ -1.40B | NT$ -1.19B | NT$ -873.35M | NT$ 2.84B | |
| NT$ 11.57B | NT$ -1.17B | NT$ -1.11B | NT$ -588.91M | NT$ 2.60B | |
| NT$ 9.32B | NT$ -1.10B | NT$ -995.42M | NT$ -575.62M | NT$ 1.82B | |
| Per Share Metrics | |||||
| Basic EPS | NT$ 12.33 | NT$ -1.55 | NT$ -1.50 | NT$ -0.89 | NT$ 2.86 |
| Diluted EPS | NT$ 12.33 | NT$ -1.55 | NT$ -1.50 | NT$ -0.89 | NT$ 2.78 |
| Weighted Average Shares Outstanding | 756.11M | 709.82M | 663.61M | 644.64M | 635.10M |
| Weighted Average Shares Outstanding (Diluted) | 756.11M | 709.82M | 663.95M | 644.76M | 666.58M |
Currency in TWD

